Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis
Public ClinicalTrials.gov record NCT00988247. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Study to Assess the Long-term Efficacy and Safety of BDP HFA Nasal Aerosol (320 mcg, Once Daily) in Adult and Adolescent Subjects (12 Years of Age and Older) With Perennial Allergic Rhinitis (PAR)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Subjects with perennial allergic rhinitis will be randomized to 320 mcg of beclomethasone dipropionate (BDP) using a hydrofluoroalkane (HFA) propellant or placebo as a nasal aerosol. The subjects will be followed for safety and efficacy for a period of 30 or 52 weeks. BDP HFA is a steroid which is currently FDA approved for the treatment of asthma. BDP-HFA should be safe and effective as a "dry" nasal aerosol which may be preferred by some patients.
Study identification
- NCT ID
- NCT00988247
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 529 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2009 (Actual)
- Primary completion
- Feb 28, 2011 (Actual)
- Completion
- Feb 28, 2011 (Actual)
- Last update posted
- Dec 3, 2021
2009 – 2011
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Clinical Sudy Site | Oxford | Alabama | 36203 | — |
| Teva Clinical Study Site | Encinitas | California | 92024 | — |
| Teva Clinical Study Site | Huntington Beach | California | 92647 | — |
| Teva Clinical Study Site | San Diego | California | 92120 | — |
| Teva Clinical Study Site | Stockton | California | 95207 | — |
| Teva Clinical Study Site | Colorado Springs | Colorado | 80907 | — |
| Teva Clinical Study Site | Atlanta | Georgia | 30342 | — |
| Teva Clinical Study Site | Stockbridge | Georgia | 30281 | — |
| Teva Clinical Study Site | Normal | Illinois | 61761 | — |
| Teva Clinical Study Site | Lenexa | Kansas | 66215 | — |
| Teva Clinical Study Site | Overland Park | Kansas | 66210 | — |
| Teva Clinical Study Site | Metairie | Louisiana | 70006 | — |
| Teva Clinical Study Site | Wheaton | Maryland | 20902 | — |
| Teva Clinical Study Site | Ypsilanti | Michigan | 48197 | — |
| Teva Clinical Study Site | Minneapolis | Minnesota | 55402 | — |
| Teva Clinical Study Site | Plymouth | Minnesota | 55441 | — |
| Teva Clinical Study Site | Bozeman | Montana | 59718 | — |
| Teva Clinical Study Site | North Syracuse | New York | 13212 | — |
| Teva Clinical Study Site | Rochester | New York | 14618 | — |
| Teva Clinical Study Site | Rockville Centre | New York | 11570 | — |
| Teva Clinical Study Site | High Point | North Carolina | 27262 | — |
| Teva Clinical Study Site | Cincinnati | Ohio | 45231 | — |
| Teva Clinical Study Site | Sylvania | Ohio | 43560 | — |
| Teva Clinical Study Site | Eugene | Oregon | 97401 | — |
| Teva Clinical Study Site | Bethlehem | Pennsylvania | 18020 | — |
| Teva Clinical Study Site | Collegeville | Pennsylvania | 19426 | — |
| Teva Clinical Study Site | Dallas | Texas | 75231 | — |
| Teva Clinical Study Site | El Paso | Texas | 79903 | — |
| Teva Clinical Study Site | Houston | Texas | 77054 | — |
| Teva Clinical Study Site | Kerrville | Texas | 78028 | — |
| Teva Clinical Study Site | San Antonio | Texas | 78229 | — |
| Teva Clinical Study Site | Vancouver | Washington | 98664 | — |
| Teva Clinical Study Site | Greenfield | Wisconsin | 53228 | — |
| Teva Clinical Study Site | West Allis | Wisconsin | 53227 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00988247, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00988247 live on ClinicalTrials.gov.